Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07787819

Feasibility of Aktiv Gegen Sturzangst (AGES) in Assisted Living Facilities

Conditions: Fear of Falling

Sex: All
Ages: 65 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 19
Sponsor: Eric Lenouvel

Location: Domicil Spitalackerpark Bern Canton of Bern

Summary

Aktiv Gegen Sturzangst (AGES) is a multicomponent group intervention combining cognitive behavioral therapy and structured exercise to address fear of falling in older adults receiving services from assisted living facilities. This single-arm, non-randomized pilot study evaluated the feasibility of implementing AGES in three assisted living facilities in Switzerland and the feasibility of study procedures and outcome measures for a future controlled trial. Nineteen older adults participated in eight weekly group sessions delivered by trained course leaders. Feasibility outcomes included recruitment, retention, course-leader deployment, protocol adherence, completion of clinical outcome measures, and feasibility of contactless LiDAR-based gait assessment.

Eligibility Criteria

Inclusion Criteria: * Age 65 years or older * Receiving some level of care or services through a participating assisted living facility * Identified by facility staff as potentially experiencing fear of falling or expressing interest in a fall-prevention program * Able to participate safely in group sessions Exclusion Criteria: * Moderate to severe neurocognitive disorder * Unstable psychiatric illness, including an acute depressive episode or substance use disorder * Physical limitations precluding safe participation in group sessions, including blindness, severe frailty, wheelchair dependence, or requirement for full mobility assistance

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07787819). StuddyBuddy aggregates publicly available trial information.